Susceptibility of SARS-CoV-2 to UV irradiation

Christiane Silke Heilingloh, Ulrich Wilhelm Aufderhorst, Leonie Schipper, +9

American Journal of Infection Control

Radiation ExposureVirologyUv-c IrradiationMedicineRadiation Oncology +2

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

Lukas van de Sand, Maren Bormann, Mira Alt, +8

Viruses

Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro

Maren Bormann, Mira Alt, Leonie Schipper, +15

Viruses

Bioactive Ingredient CurcuminTurmeric Root ExtractMedicineHerbal MedicineImmunology +11

Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes

Maren Bormann, Mira Alt, Leonie Schipper, +7

Viruses

Chemical EngineeringDecontaminationUvc-led Disinfection BoxesCredit CardsChemical Hazard +8

Convalescent plasma treatment of critically ill intensive care <scp>COVID</scp>‐19 patients

Monika Lindemann, Veronika Lenz, Dietmar Knop, +20

Transfusion

A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication

Zsolt Ruzsics, Katja Hoffmann, André Riedl, +10

Frontiers in Microbiology

Viral ReplicationImmunologyMolecular BiologyAntiviral DrugAntiviral Drug Development +15

SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study

Johannes Korth, Benjamin Wilde, Sebastian Dolff, +13

International Journal of Environmental Research and Public Health

SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma

Monika Lindemann, Adalbert Krawczyk, Sebastian Dolff, +16

Journal of Medical Virology

Viral DiagnosticsImmunologyViral PathogenesisSars‐cov‐2‐specific HumoralImmunotherapy +20

Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age

Margarethe Konik, Monika Lindemann, Markus Zettler, +19

Journal of Clinical Medicine

Humoral ResponseImmunologyCd4 T Cell ResponsesCovid-19 EpidemiologyImmunotherapy +21

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1

Christiane Silke Heilingloh, Christopher Lull, Elissa Kleiser, +7

Vaccines